Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 122 participants.
Also called NCT04191330
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 122 participants
- Sponsor
- Biofourmis Inc.
- Registry
-
NCT04191330
-
- Other papers using this trial's data
- Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Results of the AIM-POWER Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT04191330. Randomized; no masking; primary purpose treatment. Start 2020-01-27 (actual); primary completion 2024-06-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors
- Acronym
- AIM-POWER
- Condition
- Heart Failure
- Intervention (Device)
- BiovitalsHF
- Lead sponsor
- Biofourmis Inc.
Record details
- Record id
cardio:ct-nct04191330- Content hash
cd3b01583ae42d0dac4909a413d6edf77a5eff8d33154ae54b4c9e5cab5e325c